Gland Pharma will invest $21 million in its US subsidiary, which will acquire a 60% stake in newly incorporated Novelstar Pharma as the company expands in America.
Gland Pharma will invest $21 million in its US subsidiary, which will acquire a 60% stake in newly incorporated Novelstar Pharma as the company expands in America.